Rachel Herder (VP of Intellectual Property at Mammoth Biosciences), David Hoffman (VP of Intellectual Property & Transactions Cargo Therapeutics), Jamie Kitano (Senior Director Corporate Counsel Star Therapeutics), and Micheal Hebert (Shareholder at Greenberg Traurig) discuss bridging academia and industry, technology transfer, and leveraging research for commercialisation.